Larvol Delta - ASLAN-Pharmaceuticals-Announces-Acceptance-of-Two-LateBreaking-Abstracts-for-ePoster-Presentation-at-the-51st-Annual-European-Society-for-Dermatological-Research-Meeting

eblasakimab (ASLAN004) - ASLAN Pharma

https://www.globenewswire.com/news-release/2022/09/13/2514821/0/en/ASLAN-Pharmaceuticals-Announces-Acceptance-of-Two-Late-Breaking-Abstracts-for-e-Poster-Presentation-at-the-51st-Annual-European-Society-for-Dermatological-Research-Meeting.html

Sep 13, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next